Interrupted versus uninterrupted novel oral anticoagulant peri-implantation of cardiac device: A single-center randomized prospective pilot trial.
Danilo RicciardiAntonio CretaIginio ColaioriDomenico ScordinoLaura RagniFrancesco PicarelliVito CalabreseRui Andre ProvidenciaAdam IoannouGermano Di SciascioPublished in: Pacing and clinical electrophysiology : PACE (2018)
Despite the paucity of bleeding events, data from this pilot study suggest that uninterrupted NOAC therapy for CIED implantation appears to be as safe as NOAC interruption and does not increase bleeding complications.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- catheter ablation
- direct oral anticoagulants
- double blind
- open label
- heart failure
- venous thromboembolism
- left ventricular
- electronic health record
- phase iii
- placebo controlled
- risk factors
- randomized controlled trial
- clinical trial
- machine learning
- deep learning
- data analysis